SCHEMBL24528819

SCHEMBL24528819

CC(=O)C1CCN(CCn2cc(C)cn2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 4/20 0.37
KMT2A Q03164 1/20 0.37
KCNH2 Q12809 2/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
PLAA Q9Y263 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
CYP46A1 Q9Y6A2 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
TERT O14746 1/20 0.34
WNT1 P04628 1/20 0.34
GSK3B P49841 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17340938 0.87 ALPI (0.37) LMNAHTTSMN1; SMN2GAAKMT2A
SCHEMBL19446234 0.81 ACHE (0.41) KMT2ASIGMAR1ALDH1A1
SCHEMBL24528818 0.80 ALPI (0.41) LMNAHTTSMN1; SMN2ALPIALPG
SCHEMBL11946810 0.77 HRH3 (0.42) LMNAHTTSMN1; SMN2GAAKMT2A
SCHEMBL22790870 0.77 CRHR1 (0.40) HTTKMT2AKCNH2
SCHEMBL15034175 0.76 IGF1R (0.38) LMNAHTTSMN1; SMN2GAAKMT2A
SCHEMBL12285332 0.76 NOS3 (0.38) LMNAHTTSMN1; SMN2GAAKMT2A
SCHEMBL6937374 0.74 JAK2 (0.41) LMNA
SCHEMBL14728604 0.74 ALDH1A1 (0.40) LMNAHTTSMN1; SMN2GAAKMT2A
SCHEMBL20376673 0.73 LMNA (0.35) LMNAHTTSMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023242598-A1 BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2023-12-21 WO disclosed
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 WO disclosed